Indivior Pharmaceuticals Free Cash Flow (FCF) History (INDV)
Indivior Pharmaceuticals reported −$93.0M in free cash flow for fiscal 2025, a decrease of $100.0M from the previous fiscal year, with a free cash flow margin of −7.51%.
View full Indivior Pharmaceuticals company overviewIndivior Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$93.0M | −$100.0M | — | −7.51% |
| 2024 | 2024-12-31 | $7.0M | $315.0M | — | +0.59% |
| 2023 | 2023-12-31 | −$308.0M | −$299.0M | — | −28.18% |
| 2022 | 2022-12-31 | −$9.0M | −$358.0M | — | −1.00% |
| 2021 | 2021-12-31 | $349.0M | — | — | +44.12% |
Indivior Pharmaceuticals quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $222.0M | $81.0M | +57.45% | +64.72% |
| Q1 2026 | 2026-03-31 | −$29.0M | −$99.0M | — | −9.15% |
| Q4 2025 | 2025-12-31 | −$245.0M | −$212.0M | — | −68.63% |
| Q3 2025 | 2025-09-30 | −$59.0M | −$54.0M | — | −18.79% |
| Q2 2025 | 2025-06-30 | $141.0M | $57.0M | +67.86% | +46.69% |
| Q1 2025 | 2025-03-31 | $70.0M | $109.0M | — | +26.32% |
| Q4 2024 | 2024-12-31 | −$33.0M | — | — | −11.07% |
| Q3 2024 | 2024-09-30 | −$5.0M | — | — | −1.63% |
| Q2 2024 | 2024-06-30 | $84.0M | — | — | +28.09% |
| Q1 2024 | 2024-03-31 | −$39.0M | — | — | −13.73% |
Indivior Pharmaceuticals free cash flow growth trends
Indivior Pharmaceuticals's latest reported quarter, Q2 2026, generated $222.0M in free cash flow, an increase of 57.45% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Indivior Pharmaceuticals filings at SEC.gov ↗